Skip to the page

Data / Form D filings / Keygen Labs, Inc.

Keygen Labs, Inc.: Form D filing

Keygen Labs, Inc., a technology company in New York, NY, filed a Form D with the SEC in 2023. The latest, on November 14, 2023, reports $3.5 million sold of a $3.6 million offering to 16 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
275 W 96TH STREET, APT 26F, New York, NY, 10025
Phone
(917) 603-5609
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1997604

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Nov 14, 2023New notice$3,635,000$3,475,000$160,00016Jul 8, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
UTKARSH SINHAExecutive Officer, Director
ABHINAV BHARDWAJExecutive Officer
SIDDHARTH JAINDirector

Other technology companies in New York that filed recently

Every Form D from the week of Nov 13, 2023 · All recent filings in New York · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Keygen Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.